His primary scientific interests are in Apoptosis, Molecular biology, Fas receptor, Cell biology and Fas ligand. Many of his research projects under Apoptosis are closely connected to Tumor Necrosis Factor Decoy Receptors with Tumor Necrosis Factor Decoy Receptors, tying the diverse disciplines of science together. His biological study deals with issues like Cytotoxic T cell, which deal with fields such as Viral replication, Virology and Virus.
David H. Lynch works mostly in the field of Cell biology, limiting it down to topics relating to T cell and, in certain cases, Biochemistry and Cell surface receptor. The concepts of his Fas ligand study are interwoven with issues in Southern blot, Transfection, Point mutation, Complementary DNA and Gene cluster. In his work, Immune system is strongly intertwined with Cancer research, which is a subfield of Tumor necrosis factor alpha.
David H. Lynch focuses on Immunology, Molecular biology, Cell biology, Apoptosis and Cytotoxic T cell. His Immunology study frequently links to adjacent areas such as In vivo. His Molecular biology study also includes
His Cell biology research includes themes of Cell and Cell type. David H. Lynch has included themes like Tumor necrosis factor alpha and Receptor in his Apoptosis study. David H. Lynch combines subjects such as CD3 and Macrophage with his study of Cytotoxic T cell.
David H. Lynch spends much of his time researching Immunology, Apoptosis, Cell biology, Immune system and Molecular biology. In his study, Cell culture and Tumor necrosis factor alpha is inextricably linked to Jurkat cells, which falls within the broad field of Apoptosis. His research in the fields of Signal transduction overlaps with other disciplines such as Population.
David H. Lynch interconnects Cytotoxic T cell, Viral replication and Virology in the investigation of issues within Immune system. His Molecular biology study incorporates themes from In vitro, Progenitor cell, Dendritic cell homeostasis, Growth factor and APAF1. His biological study spans a wide range of topics, including In vivo, Lymphokine, CD8 and CD40.
The scientist’s investigation covers issues in Immunology, Cell biology, Signal transduction, T lymphocyte and Virology. His studies deal with areas such as Progenitor cell, Cell, Haematopoiesis and FMS-like tyrosine kinase 3 ligand as well as Immunology. His Cell biology research is multidisciplinary, incorporating elements of Apoptosis, Receptor, Ligand and Fas receptor.
His Signal transduction research incorporates elements of HSL and HSV, Cell type and Chromosomal translocation. His studies in T lymphocyte integrate themes in fields like Cytotoxic T cell and Viral replication. He studies Virus which is a part of Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
Henning Walczak;Robert E. Miller;Kiley Ariail;Brian Gliniak.
Nature Medicine (1999)
Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
Thomas Brunner;Rona J. Mogil;Drake LaFace;Nam Jin Yoo.
Fas ligand mediates activation-induced cell death in human T lymphocytes.
M R Alderson;T W Tough;T Davis-Smith;S Braddy.
Journal of Experimental Medicine (1995)
Induction of apoptosis in mature T cells by tumour necrosis factor.
Lixin Zheng;Galen Fisher;Robert E. Miller;Jacques Peschon.
Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells.
Hilary J. McKenna;Kim L. Stocking;Robert E. Miller;Kenneth Brasel.
Intracellular Regulation of TRAIL-Induced Apoptosis in Human Melanoma Cells
Thomas S. Griffith;Wilson A. Chin;Glenn C. Jackson;David H. Lynch.
Journal of Immunology (1998)
Fas and FasL in the homeostatic regulation of immune responses.
David H. Lynch;Fred Ramsdell;Mark R. Alderson.
Immunology Today (1995)
Fas transduces activation signals in normal human T lymphocytes.
M R Alderson;R J Armitage;E Maraskovsky;T W Tough.
Journal of Experimental Medicine (1993)
TRAIL: a molecule with multiple receptors and control mechanisms
Thomas S Griffith;David H Lynch.
Current Opinion in Immunology (1998)
The CD95 receptor: apoptosis revisited.
Marcus E. Peter;Ralph C. Budd;Julie Desbarats;Stephen M. Hedrick.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: